Before ambulating a client with Parkinson's disease on levodopa/carbidopa, what assessment is crucial?

Before ambulating a client with Parkinson's disease on levodopa/carbidopa, what assessment is crucial?

• A. Blood glucose levels
• B. Postural (orthostatic) vital signs
• C. Range of motion
• D. Neurological status

Answer: (B)

In patients with Parkinson's disease, especially those on levodopa/carbidopa, assessing postural (orthostatic) vital signs is crucial before ambulation. This is because levodopa and carbidopa can lead to changes in blood pressure regulation, often resulting in orthostatic hypotension. This condition can provoke dizziness, lightheadedness, or fainting when a patient changes position from lying down to standing up. By monitoring vital signs in different postures, healthcare providers can identify any significant drops in blood pressure that might increase the risk of falls or other injuries during ambulation. This assessment helps ensure the patient's safety and allows for appropriate interventions if needed before mobility activities are initiated. The other assessments, while important, are not as directly related to the immediate safety concerns associated with ambulating a patient on these medications.

In patients with Parkinson's disease, especially those on levodopa/carbidopa, assessing postural (orthostatic) vital signs is crucial before ambulation. This is because levodopa and carbidopa can lead to changes in blood pressure regulation, often resulting in orthostatic hypotension. This condition can provoke dizziness, lightheadedness, or fainting when a patient changes position from lying down to standing up. By monitoring vital signs in different postures, healthcare providers can identify any significant drops in blood pressure that might increase the risk of falls or other injuries during ambulation. This assessment helps ensure the patient's safety and allows for appropriate interventions if needed before mobility activities are initiated.

The other assessments, while important, are not as directly related to the immediate safety concerns associated with ambulating a patient on these medications.